Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 33 Carcinoma, Non-Small-Cell Lung 19 Squamous Cell Carcinoma of Head and Neck 18 Esophageal Neoplasms 17 Uterine Cervical Neoplasms 11 Nasopharyngeal Carcinoma 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 9 Oropharyngeal Neoplasms 8 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Squamous Cell 6 Stomach Neoplasms 4 Neoplasms 4 Mouth Neoplasms 4 Glioblastoma 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Urinary Bladder Neoplasms 3 Pathologic Complete Response 3 Hypopharyngeal Neoplasms 3 Thymoma 2 Resectable Esophageal Cancer 2 Neoplasms by Site 2 Nasopharyngeal Neoplasms 2 NSCLC 2 Lymphoma 2 Lung Neoplasms 2 Locally Advanced Malignant Neoplasm 2 Laryngeal Neoplasms 2

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inoperable œsophageal Cancer × Chemoradiotherapy × Clear all

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡